SETD2 and nonpapillary renal cell carcinoma: Multiple driver gene alterations defined as VHL mutation plus two or more additional mutations in PBRM1, SETD2, BAP1 or PTEN in analogy to (3) were detected in seven of 17 ccRCC patients (41.2%).